Abemaciclib Dose Escalation to Maintain Intensity (ADE-MI)
Clinical trial NCT06169371 · RECRUITING
Trial details
- NCT number
- NCT06169371
- Sponsor
- University of Illinois at Chicago
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-28
- Primary completion
- 2030-11-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.